Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Adenocarcinoma 1

Interventions

Docetaxel 3 regorafenib 2 Doxorubicin 2 trifluridine tipiracil drug combination 1 pegfilgrastim 1 enzalutamide 1 darolutamide 1 bicalutamide 1 apalutamide 1 abiraterone 1 Triptorelin Pamoate 1 Trifluridine 1 Surgical Procedures, Operative 1 Pancreaticoduodenectomy 1 Paclitaxel 1 Nivolumab 1 Irinotecan 1 Cyclophosphamide 1 Cisplatin 1 CP protocol 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Adenocarcinoma × darolutamide × Clear all

NCT06592924 2026-04-14

TRIPLE-SWITCH

Canadian Cancer Trials Group

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡